Samsung Biologics will acquire the Rockville assets for $280 million with closing anticipated toward the end of Q1 of 2026.

Use this brand-new eBook from Cytiva to learn more about the oligonucleotide market as a whole and about the full workflow solutions available today. We hope you enjoy it!

In this GEN webinar, DNA synthesis experts Michael Junkin, PhD, and Brittany Enzmann, PhD, will provide an exclusive first look at Elegen’s GEN II Cell-Free DNA production platform that combines ...

Liver cells exposed to a high fat diet revert to an immature state that is more susceptible to cancer-causing mutations.

A new study shows how histones undergo correct chemical modifications during synthesis to guide new therapies.

New findings could aid future development of more efficient therapeutic strategies in the context of regenerative medicine and aging.

Data from a disease model showed that HSV1 infection caused tau hyperphosphorylation, forming aggregates that trapped viral ...

JAX and the NYSCF celebrated the official launch of their unified organization with a ribbon-tying ceremony at NYSCF’s Manhattan research facilities.

Researchers suggest that MultiCell could potentially be used to discern early patterns of disease, such as in asthma.

Vaccines that display filovirus surface proteins on engineered, self-assembling protein nanoparticles improve immune system detection of the virus.

A new brain-computer interface promises ultra-high resolution neural recording and wireless operation in a very small form.

AI can move beyond prediction to purposeful molecular design, creating proteins that meet clearly defined research and therapeutic goals.